METHOD OF TREATMENT AND IMPROVING THE QUALITY OF LIFE OF PATIENTS WITH SYNDROME DYSPEPSIA IN COMBINATION WITH OBESITY

摘要

A method of treating patients with the syndrome of dyspepsia in combination with overweight comprising determining the level of anxiety (HARS) and depression (HDRS) by Hamilton scale, evaluating nutritional status using bioimpedasmetrii, severity of sleep disorders, the evaluation type of feeding behavior, the evaluation mode and circadian rhythm meal glucose level estimation, immunoreactive insulin, cholesterol, high density lipoprotein (HDL), in the venous blood triglycerides, glucose tolerance assessment, evaluation of taste sensitivity, otse ku quality of life, characterized in that the following options into account when selecting the mode of differentiated purpose of therapy if the patient revealed dyslipidemia and one of the problems: carbohydrate tolerance or changes in the level of immunoreactive insulin, the prescribers dibikor 500 mg per day for three months; if the patient revealed both dyslipidemia disorders: tolerance to carbohydrates and a change in the level of immunoreactive insulin dibikor the prescribed drug in a dose of 1000 mg per day for three months; if the patient has an obese with a BMI of 30 to 34.9 conventional units according bioimpedansmetrii percentage of active cell mass (ACM) is from 45 to 55 percent, dietressa prescribed drug in a dose of 1 tablet 3 times a day for a month; if the patient has an obese with a BMI of 30 to 34.9 and ATM is less than 45 percent, or greater than 55 percent, dietressa administered drug dose of 2 tablets three times a day for a month; if one month after initiation of treatment not reached the target weight loss - 5 percent or more of the starting